Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Paul Anthony Camacho López

doi:10.1016/s0140-6736(15)00469-9

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

Research output: Articles / Notes › Scientific Article › peer-review

301 Scopus citations

Original language	English
Journal	The Lancet
DOIs	https://doi.org/10.1016/s0140-6736(15)00469-9
State	Published - Jan 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s0140-6736(15)00469-9

Cite this

@article{c1dfda5e6f284772a0fa22dfef1eb7e8,

title = "Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data",

author = "{Camacho L{\'o}pez}, {Paul Anthony}",

year = "2016",

month = jan,

doi = "10.1016/s0140-6736(15)00469-9",

language = "Ingl{\'e}s",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

}

TY - JOUR

T1 - Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

AU - Camacho López, Paul Anthony

PY - 2016/1

Y1 - 2016/1

UR - http://dx.doi.org/10.1016/s0140-6736(15)00469-9

U2 - 10.1016/s0140-6736(15)00469-9

DO - 10.1016/s0140-6736(15)00469-9

M3 - Artículo Científico

SN - 0140-6736

JO - The Lancet

JF - The Lancet

ER -

Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data

UN SDGs

Access to Document

Other files and links

Cite this